Tami Martin, R.N.

2019

In 2019, Tami Martin, R.N. earned a total compensation of $874.8K as Senior Vice President, Regulatory Affairs at Supernus Pharmaceuticals, a 21% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$91,400
Option Awards$424,540
Salary$316,891
Other$41,988
Total$874,819

RN received $424.5K in option awards, accounting for 49% of the total pay in 2019.

RN also received $91.4K in non-equity incentive plan, $316.9K in salary and $42K in other compensation.

Rankings

In 2019, Tami Martin, R.N.'s compensation ranked 9,860th out of 13,971 executives tracked by ExecPay. In other words, RN earned more than 29.4% of executives.

ClassificationRankingPercentile
All
9,860
out of 13,971
29th
Division
Manufacturing
3,982
out of 5,698
30th
Major group
Chemicals And Allied Products
1,516
out of 2,197
31st
Industry group
Drugs
1,296
out of 1,883
31st
Industry
Pharmaceutical Preparations
963
out of 1,395
31st

Pay ratio

Tami Martin, R.N.'s Pay$874,819
Median Employee's Pay$135,666
Pay Ratio

6

to 1

In 2019, the annual total compensation of Tami Martin, R.N. was $874,819.

The annual total compensation of the median employee at Supernus Pharmaceuticals was $135,666.

The ratio of Tami Martin, R.N.'s pay to the pay of median employee was therefore 6 to one.

Source: SEC filing on April 24, 2020.

RN's colleagues

We found four more compensation records of executives who worked with Tami Martin, R.N. at Supernus Pharmaceuticals in 2019.

2019

Jack Khattar

Supernus Pharmaceuticals

Chief Executive Officer

2019

Stefan Schwabe

Supernus Pharmaceuticals

Chief Medical Officer

2019

Gregory Patrick

Supernus Pharmaceuticals

Chief Financial Officer

2019

Padmanabh Bhatt

Supernus Pharmaceuticals

Chief Scientific Officer

News

You may also like